It’s no secret that exchange-traded funds (ETFs) have been the biggest competitor of mutual funds. In a recent article published by Time.com, the growth rates of mutual funds and ETFs are discussed.

Although ETFs are growing at a much faster pace, mutual funds have been around for 91 years.

To read the full article, click here.

Zacks.com recently published an article highlighting four European mutual funds to consider. The list included the following funds.

• Invesco European Growth Investor (EGINX)
• Deutsche World Dividend A (SERAX)
• Morgan Stanley European Equity A (EUGAX)
• Henderson European Focus A (HFEAX)

To read the full article, click here.

Zacks.com recently published an article highlighting mutual fund gainers over the 6-year bull run. The list included the following funds:

• ProFunds Biotechnology UltraSector Investor (BIPIX)
• Prudential Jennison Health Sciences A (PHLAX)
• T. Rowe Price Health Sciences (PRHSX)
• Franklin Biotechnology Discovery A (FBDIX)
• Prudential Jennison Health Sciences B (PHLBX)

To read the full article, click here.

Zacks.com recently published an article highlighting 3 market neutral mutual funds. The list included the following funds:

• JPMorgan Multi-Cap Market Neutral A (OGNAX)
• Gateway A (GATEX)
• TFS Market Neutral (TFSMX)

To read the full article, click here.